Congress CBD

For the first time, Congress officially addressed the impact of the U.S. Food and Drug Administration’s (FDA) inaction regarding the regulations of CBD products. What Happened: In an opening statement at the hearing, “Hemp in the Modern World: The Years long Wait for FDA Action,”...

The U.S. Food and Drug Administration has not given up on regulating CBD and hemp-derived products in a way that would be safe for consumers and producers. Last week, the administration held a virtual panel “A New Way Forward for Cannabidiol and Other Hemp Products” for ...